Getting ready for neuroimaging in the new era of amyloid targeting therapies

During this symposium, you will learn about Amyloid Related Imaging Abnormalities (ARIA) management and the evolving role of PET biomarkers in Alzheimer’s treatment. You will also gain insights into current amyloid therapies and cutting-edge imaging advancements, that will help you determine your patient’s pathology as well as the right treatment path.